Search

Displaying results 5221 - 5230 of 8469 in total
  1. Drug

    N-6022

    go.drugbank.com/drugs/DB12206
    Investigational

    N6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis.

  2. Drug

    Terameprocol

    go.drugbank.com/drugs/DB12226
    Investigational

    Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.

  3. Drug

    LY-2608204

    go.drugbank.com/drugs/DB12284
    Investigational

    LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

  4. Drug

    Evocalcet

    go.drugbank.com/drugs/DB12388
    Investigational

    Evocalcet has been used in trials studying the treatment of Hyperparathyroidism and Secondary Hyperparathyroidism.

  5. Drug

    VTP-27999

    go.drugbank.com/drugs/DB12416
    Investigational

    VTP-27999 has been used in trials studying the basic science of Renal Function.

  6. Drug

    MK-3207

    go.drugbank.com/drugs/DB12424
    Investigational

    Mk3207 has been used in trials studying the treatment of Migraine and Migraine Disorders.

  7. Drug

    Netivudine

    go.drugbank.com/drugs/DB12606
    Investigational

    Netivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.

  8. Drug

    Batefenterol

    go.drugbank.com/drugs/DB12526
    Investigational

    Batefenterol has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  9. Drug

    VA-MENGOC-BC®

    go.drugbank.com/drugs/DB15800
    Experimental

    As there already exists a polysaccharide-based vaccine against meningococcal disease originating from serogroups A,C,W135, and Y, this vaccine was created for use against serogroups B and C. … As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.

  10. Drug

    GFT14

    go.drugbank.com/drugs/DB05061
    Experimental

    Orally absorbed GFT14 has absolutely no structural link with current treatments for dyslipidemia (statin or fibrate based). … GFT14 aims to target mixed dyslipidemia of type IIb (high levels of triglycerides and LDL-C) as one of the major indications of cardiometabolic disease.